316 related articles for article (PubMed ID: 22530644)
1. HRT decreases DNA and lipid oxidation in postmenopausal women.
Escalante Gómez C; Quesada Mora S
Climacteric; 2013 Feb; 16(1):104-10. PubMed ID: 22530644
[TBL] [Abstract][Full Text] [Related]
2. The oxidative metabolism of estrogen modulates response to ERT/HRT in postmenopausal women.
Armamento-Villareal RC; Napoli N; Klug T; Civitelli R
Bone; 2004 Sep; 35(3):682-8. PubMed ID: 15336604
[TBL] [Abstract][Full Text] [Related]
3. Estrogen plus progestin increase superoxide dismutase and total antioxidant capacity in postmenopausal women.
Unfer TC; Figueiredo CG; Zanchi MM; Maurer LH; Kemerich DM; Duarte MM; Konopka CK; Emanuelli T
Climacteric; 2015 Jun; 18(3):379-88. PubMed ID: 25236970
[TBL] [Abstract][Full Text] [Related]
4. Effect of lower dose of oral conjugated equine estrogen on size and oxidative susceptibility of low-density lipoprotein particles in postmenopausal women.
Wakatsuki A; Okatani Y; Ikenoue N; Shinohara K; Watanabe K; Fukaya T
Circulation; 2003 Aug; 108(7):808-13. PubMed ID: 12900341
[TBL] [Abstract][Full Text] [Related]
5. Serum estrogen level after hormone replacement therapy and body mass index in postmenopausal and bilaterally ovariectomized women.
Yasui T; Uemura H; Umino Y; Takikawa M; Saito S; Kuwahara A; Matsuzaki T; Maegawa M; Furumoto H; Miura M; Irahara M
Maturitas; 2005 Jan; 50(1):19-29. PubMed ID: 15590210
[TBL] [Abstract][Full Text] [Related]
6. Effects of estrogen-only therapy on LDL oxidation in women with hysterectomy: does paraoxonase genotype play a role?
Akçay YD; Sagin FG; Sendağ F; Oztekin K; Sozmen EY
Maturitas; 2006 Feb; 53(3):325-32. PubMed ID: 16023312
[TBL] [Abstract][Full Text] [Related]
7. Assessment of DNA nucleo base oxidation and antioxidant defense in postmenopausal women under hormone replacement therapy.
Akcay T; Dincer Y; Saygili EI; Seyisoğlu H; Ertunğalp E
Indian J Med Sci; 2010 Jan; 64(1):17-25. PubMed ID: 22301805
[TBL] [Abstract][Full Text] [Related]
8. Effects of low-dose, continuous combined hormone replacement therapy on sleep in symptomatic postmenopausal women.
Gambacciani M; Ciaponi M; Cappagli B; Monteleone P; Benussi C; Bevilacqua G; Vacca F; Genazzani AR
Maturitas; 2005 Feb; 50(2):91-7. PubMed ID: 15653005
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide in postmenopausal women taking three different HRT regimens.
Kesim MD; Aydin Y; Erdemir M; Atis A
Maturitas; 2005 Jan; 50(1):52-7. PubMed ID: 15590214
[TBL] [Abstract][Full Text] [Related]
10. Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy.
Simon JA; Liu JH; Speroff L; Shumel BS; Symons JP
Am J Obstet Gynecol; 2003 Jan; 188(1):92-9. PubMed ID: 12548201
[TBL] [Abstract][Full Text] [Related]
11. Hormone replacement therapy in postmenopausal women.
Yasui T; Uemura H; Takikawa M; Irahara M
J Med Invest; 2003 Aug; 50(3-4):136-45. PubMed ID: 13678382
[TBL] [Abstract][Full Text] [Related]
12. Assessment of DNA damage in postmenopausal women under hormone replacement therapy.
Ozcagli E; Sardas S; Biri A
Maturitas; 2005 Jul; 51(3):280-5. PubMed ID: 15978971
[TBL] [Abstract][Full Text] [Related]
13. Fatty acid composition of serum phospholipid of premenopausal women and postmenopausal women receiving and not receiving hormone replacement therapy.
Stark KD; Park EJ; Holub BJ
Menopause; 2003; 10(5):448-55. PubMed ID: 14501607
[TBL] [Abstract][Full Text] [Related]
14. A randomized, open-label study of conjugated equine estrogens plus medroxyprogesterone acetate versus tibolone: effects on symptom control, bleeding pattern, lipid profile and tolerability.
Baracat EC; Barbosa IC; Giordano MG; Haidar MA; Marinho RM; Menegocci JC; Morais KM; Tomaz G; Wehba S
Climacteric; 2002 Mar; 5(1):60-9. PubMed ID: 11974560
[TBL] [Abstract][Full Text] [Related]
15. Role of ovarian hormones in the regulation of protein metabolism in women: effects of menopausal status and hormone replacement therapy.
Toth MJ; Sites CK; Matthews DE
Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E639-46. PubMed ID: 16684855
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of oral conjugated equine estrogen and transdermal estrogen on atherosclerotic vascular disease risk markers and endothelial function in healthy postmenopausal women.
Ho JY; Chen MJ; Sheu WH; Yi YC; Tsai AC; Guu HF; Ho ES
Hum Reprod; 2006 Oct; 21(10):2715-20. PubMed ID: 16807281
[TBL] [Abstract][Full Text] [Related]
17. Lipid, protein, DNA oxidation and antioxidant status in rheumatoid arthritis.
Seven A; Güzel S; Aslan M; Hamuryudan V
Clin Biochem; 2008 May; 41(7-8):538-43. PubMed ID: 18313405
[TBL] [Abstract][Full Text] [Related]
18. Comparison of continuation of postmenopausal hormone replacement therapy: transdermal versus oral estrogen.
Ettinger B; Pressman A; Bradley C
Menopause; 1998; 5(3):152-6. PubMed ID: 9774760
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the antioxidant effects of equine estrogens, red wine components, vitamin E, and probucol on low-density lipoprotein oxidation in postmenopausal women.
Bhavnani BR; Cecutti A; Gerulath A; Woolever AC; Berco M
Menopause; 2018 Nov; 25(11):1214-1223. PubMed ID: 30358716
[TBL] [Abstract][Full Text] [Related]
20. Undercarboxylated osteocalcin concentration in postmenopausal women receiving hormone therapy daily and on alternate days.
Yasui T; Uemura H; Umino Y; Yamada M; Kuwahara A; Matsuzaki T; Maegawa M; Furumoto H; Miura M; Irahara M
Menopause; 2006; 13(2):314-22. PubMed ID: 16645545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
